Explore News By Topic

08/22/2019

The Prostate Cancer Foundation and the Movember Foundation Announce 2019 Challenge Award Winners

The Prostate Cancer Foundation (PCF) and the Movember Foundation today announced three new Movember Foundation-PCF Challenge Awards. These are granted to teams at some of the world’s leading cancer research institutions. They will receive a total of $2.5 million to support cross-disciplinary pioneering research toward the goal of finding a... Read More

07/30/2019

FDA Approves Bayer’s Nubeqa® (darolutamide), a New Treatment for Men with Non-Metastatic Castration-Resistant Prostate Cancer

WHIPPANY, N.J., July 30, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today approved Nubeqa® (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).  The FDA approval is based on the Phase III ARAMIS trial evaluating Nubeqa plus androgen deprivation... Read More

07/23/2019

Gene test picks out prostate cancer patients who could benefit from ‘search-and-destroy’ medicine

Original Press Release Issued by: The Institute of Cancer Research, London Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports. An emerging class of drugs are made up of a radioactive particle that... Read More

06/26/2019

Newly defined cancer driver is Fast, Furious and Loud

Original Press Release Issued by: University of Michigan Medicine ANN ARBOR, Michigan — The Fast and the Furious movie franchise meets the Fast N’ Loud television series to define an oncogene that drives 35% of prostate cancers. A new study from researchers at the University of Michigan Rogel Cancer Center... Read More

06/12/2019

New Class of Life-Extending Drugs for Men with Metastatic Hormone-Sensitive Prostate Cancer

At the 2019 American Society of Clinical Oncology (ACSO) Annual Meeting, results presented by two PCF-funded investigators from pivotal phase 3 clinical trials will likely lead to approval of a new class of life-extending treatment options for men with metastatic hormone-sensitive prostate cancer (mHSPC). mHSPC refers to men whose prostate... Read More

05/30/2019

THE PROSTATE CANCER FOUNDATION AND MAJOR LEAGUE BASEBALL KICK OFF 24th ANNUAL HOME RUN CHALLENGE ON JUNE 1st

One in 9 U.S. men will be diagnosed with prostate cancer which is equivalent to at least one player on a baseball team One man dies from prostate cancer every 17 minutes which is roughly equivalent to one player per inning More than 31,000 men will die from prostate cancer... Read More

05/22/2019

Black men less likely than nonblack patients to adopt active surveillance for low-risk prostate cancer

Original Press Release Issued by: Dana-Farber Cancer Institute Overall active surveillance rates are up, though the increase is significantly smaller for black patients Black men may be deterred by both socioeconomic factors and providers’ hesitation given concern for underlying aggressive disease BOSTON – At a time when a growing number of... Read More

05/21/2019

A New Standard of Care for Low-Volume Metastatic Prostate Cancer

Men diagnosed with metastatic prostate cancer will often not undergo local treatments of the primary prostate tumor, such as surgery or radiation. Primary hormone therapy (also known as androgen deprivation therapy or ADT) has long been the standard of care, although recently the addition of docetaxel or abiraterone to ADT... Read More

05/14/2019

Natural Killer Cells for Prostate Cancer Immunotherapy

Achoo! Caught a nasty cold from that co-worker who insisted on bringing her hacking cough to the office? No problem….your immune system will fight the invading virus and you’ll be feeling better in a few days. We’re used to thinking of the immune system as the body’s defense against colds,... Read More

05/08/2019

Prostate Cancer Foundation’s Robust Collection of New Patient Resources, Including New 2019 Prostate Cancer Patient Guide Now Available

- Updated Publication: Prostate Cancer Patient Guide - Updated Publication: Additional Facts for African-American Men and Their Families - New Online Tool: Prostate Cancer Clinical Trial Finder - New Article Series: Thoughts on Prostate Cancer by Janet Farrar Worthington - Online Support Groups: Facebook Communities for Patients, Caregivers and Survivors... Read More